Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 18, 2021
ERS Genomics and ZeClinics have announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
read more
Enyo Pharma has decided to open its first wholly owned subsidiary in Melbourne, Australia, because of its clinical trials development capabilities and conditions offered by the government.
read more
Enable Injections has entered into a multi-product development agreement with Sanofi S.A.
read more
Emergent BioSolutions will collaborate with Novavax to support bringing into the clinic Novavax’s novel experimental vaccine candidate to protect against coronavirus disease (COVID-19).
read more
Eleva is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19.
read more
Wednesday, February 19, 2020
Dr. Reddy’s Laboratories has entered into a definitive agreement with Wockhardt Limited to acquire select divisions of its branded generics business.
read more
Dr. Reddy’s and its subsidiary, Promius Pharma announced the filing of NDA for its migraine candidate DFN-02 with the FDA.
read more
Dr. Reddy’s announced the launch of Ziprasidone Mesylate for Injection, 20 mg (base)/mL Single-dose Vials, the generic equivalent of Geodon.
read more
Monday, December 30, 2019
Dr. Reddy’s announced the launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial, the therapeutic generic equivalent of Nitropress® Injection.
read more
Wednesday, October 31, 2018
Dr. Reddy’s Laboratories announced the launch of Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Stratter (atomoxetine) Capsules in the United States.
read more
Dr. Reddy’s Laboratories has entered into a definitive agreement for the sale of its API manufacturing business unit located in Jeedimetla, Hyderabad, to Therapiva Private, a generics pharmaceutical company.
read more
Wednesday, November 12, 2014
DPT Laboratories, a Contract Development and Manufacturing Organization (CDMO) specializing in semi-solid and liquid dosage forms, announces the implementation of a [2]high-speed bottle filling center at its San Antonio location.
read more
Monday, February 24, 2020
Dipharma Francis announced the completion of the new cGMP Quality Control laboratory and c-GMP kilolab at its CDMO site located in Kalamazoo MI.
read more
Wednesday, January 15, 2020
Dermavant Sciences has entered into a collaboration and license agreement with Japan Tobacco for exclusive rights to develop, register and market tapinarof in Japan for psoriasis and atopic dermatitis.
read more
Debiopharm announced the signature of an exclusive license agreement with Merck KGaA, Darmstadt, Germany for the development and commercialization of xevinapant.
read more